Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Blood
|
January 1, 1984
Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy
Z Arlin, S Kempin, R Mertelsmann, et al.
Cancer Treatment Reports
|
February 1, 1983
Phase I trial of 10-deaza-aminopterin in patients with advanced cancer
V E Currie, R P Warrell, Z Arlin, et al.
Onkologie
|
June 1, 1986
High-dose cytosine-arabinoside and mitoxantrone in refractory acute myeloid leukemia: a clinical phase I/II-study
W Hiddemann, H Kreutzmann, K Straif, et al.
International Journal of Oncology
|
May 18, 2011
The safety and efficacy of gi endoscopy in patients with acute-leukemia - a review of 27 cases
B Dworkin, N Winzelberg, T Ahmed, et al.
Investigational New Drugs
|
August 1, 1992
A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion
A Mittelman, C Puccio, E Gafney, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response
W Kreis, M Lesser, D R Budman, et al.
Investigational New Drugs
|
January 1, 1990
Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced head and neck cancer
A Mittelman, S Savona, C Puccio, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
October 1, 1981
The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man
I Svet-Moldavsky, G Svet-Moldavsky, S Zinzar, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells
M Hoffman, A Mittelman, B Dworkin, et al.
Leukemia
|
June 1, 1989
Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia
D Wisniewski, A Strife, Z Arlin, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Blood
|
January 1, 1984
Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapy
Z Arlin, S Kempin, R Mertelsmann, et al.
Cancer Treatment Reports
|
February 1, 1983
Phase I trial of 10-deaza-aminopterin in patients with advanced cancer
V E Currie, R P Warrell, Z Arlin, et al.
Onkologie
|
June 1, 1986
High-dose cytosine-arabinoside and mitoxantrone in refractory acute myeloid leukemia: a clinical phase I/II-study
W Hiddemann, H Kreutzmann, K Straif, et al.
International Journal of Oncology
|
May 18, 2011
The safety and efficacy of gi endoscopy in patients with acute-leukemia - a review of 27 cases
B Dworkin, N Winzelberg, T Ahmed, et al.
Investigational New Drugs
|
August 1, 1992
A phase I pharmacokinetic study of recombinant human tumor necrosis factor administered by a 5-day continuous infusion
A Mittelman, C Puccio, E Gafney, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1992
Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response
W Kreis, M Lesser, D R Budman, et al.
Investigational New Drugs
|
January 1, 1990
Phase II trial of fludarabine phosphate (F-Ara-AMP) in patients with advanced head and neck cancer
A Mittelman, S Savona, C Puccio, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
October 1, 1981
The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man
I Svet-Moldavsky, G Svet-Moldavsky, S Zinzar, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1989
Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells
M Hoffman, A Mittelman, B Dworkin, et al.
Leukemia
|
June 1, 1989
Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia
D Wisniewski, A Strife, Z Arlin, et al.
Page
of 8